Investigación / Grupos de investigación

Grupo  27

Farmacia Hospitalaria y Farmacogenómica

Publicaciones (418)

  • Galnares, MR; Morillo-Verdugo, R; Robustillo-Cortes, MD; Vélez-Diaz-Pallarés, M; Albir, MJC; Vega, BP; López, LL; Ventura, LM; Villanueva, MF; Atorrasagasti, OM; Gutiérrez, E.

    Impact of a CMO-Based Pharmaceutical Care Model on 3-HIT Criteria in Older People Living with HIV: The DIS3HIT Project

    Patient Preference and Adherence. 2026; 20: 1-12 [doi:10.2147/PPA.S569460]

  • Climente-Martí, M; García-González, X; Torres-Bondia, FI; Lozano, J; Gómez-Navarro, V.

    Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting

    JOURNAL OF MEDICAL ECONOMICS. 2025; 28(1): 1857-1868 [doi:10.1080/13696998.2025.2575456]

  • Ripa, C; Olariaga, O; Vallinas, S; Sirvent, M; Prado, E; Romero, R; Perez, L; Terroba, P; Hernández, S; Chica, A; Gandara, MJ; Bourgon, L; Ochagavia, M; Tamayo, R; Leunda, L.

    OncoNutridos study: Prevalence of disease-related malnutrition according to GLIM criteria in cancer patients in oncohaematology day hospitals

    Clinical Nutrition ESPEN. 2025; 70: 666-675 Nº de citas: 3 [doi:10.1016/j.clnesp.2025.11.008]

  • Somoza-Fernandez, B; de Lorenzo-Pinto, A; Escudero-Vilaplana, V; Manrique-Rodriguez, S; Villanueva-Bueno, C; Martin-Barbero, ML; Redondo-Galan, C; Calatayud-Garcia, J; Gonzalez-Ramallo, V; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Standardizing hospital pharmacy practice in home hospitalization: results from a multidisciplinary Delphi consensus in Spain

    Frontiers in Public Health. 2025; 13: [doi:10.3389/fpubh.2025.1707726]

  • Jiménez, RMR; Pinto, PH; Domínguez, MC; Bellmunt, A; Vidal-Vilar, N; Soto, MDF; Juste, AD.

    Cost-Effectiveness Analysis of Abrocitinib Compared with Dupilumab for Adolescents With Severe Atopic Dermatitis in Spain

    Pharmacoeconomics-Open. 2025; 10(1): 209-213 [doi:10.1007/s41669-025-00616-9]

  • Roncero, C; Sánchez-García, A; Burguet, LC; Moreno, AF; Barbero, MLM; Aguilera-Serrano, C; Dorado, VO; Remacha, JG; Prieto, JR; Pérez-Esteve, C; Vila, MS; Solves, JJM.

    Relevant Criteria for Improving Quality of Schizophrenia Spectrum Disorders Treatment: A Delphi Study

    Healthcare. 2025; 13(22): [doi:10.3390/healthcare13222847]

  • Suárez-Casillas, P; Mejías-Trueba, M; Peñalva, G; Fontán-Díaz, F; Villanueva-Bueno, C; Herrera-Hidalgo, L; Varela-Rubio, E; Jiménez-Parrilla, F; Cisneros, JM; Gil-Navarro, MV; Guisado-Gil, AB.

    Antimicrobial Use Monitoring in Neonatal Population Using a Defined Daily Doses Method

    Neonatology. 2025; 123(1): 64-73 Nº de citas: 1 [doi:10.1159/000548869]

  • Cerezuela, MM; Moreno, FB; Ramos, JR; Pinto, AD; Chiva, ED; Rubio, MV; González, IA; Fernández, CB; Moral, LD; Lugea, AE; Garcia, MAA; Garcia, TB; Sacristán, SC; Fernández, MA; Pérez, SO; Tomás, LPD.

    Development of the critically ill patient mobile application Guide to medication reconciliation in the critically ill patient

    FARMACIA HOSPITALARIA. 2025; 49(6): 367-372 [doi:10.1016/j.farma.2025.03.021]

  • Cerezuelaa, MM; Morenob, FB; Ramosc, JR; Pintod, AD; Chivae, ED; Rubiof, MV; Gonzálezg, IA; Fernándezh, CB; Morali, LD; Lugeaj, AE; Garciak, MAA; Garcial, TB; Sacristánm, SC; Fernándezh, MA; Pérezn, SO; Tomáso, LPD.

    [Translated article] Development of the mobile application Guide to medication reconciliation in the critically ill patient

    FARMACIA HOSPITALARIA. 2025; 49(6): 367-372 Nº de citas: 1 [doi:10.1016/j.farma.2025.06.007]

  • Ribed, A; Giménez-Manzorro, A; de Lorenzo-Pinto, A; Torroba-Sanz, B; Ginel-Feito, MD; Cabrerizo-Torrente, P; Barbero, MLM; Herranz, A; Sanjurjo, M.

    Improving medication safety in the perioperative setting: development of a medication use process

    BRITISH JOURNAL OF ANAESTHESIA. 2025; 135(4): 997-1006 Nº de citas: 3 [doi:10.1016/j.bja.2025.04.034]

  • Ramos-Rodríguez, J; Bonete-Sánchez, M; Ruiz-Ramos, J; Calderon-Hernanz, B; Campino-Villegas, A; de Lorenzo-Pinto, A; García-Peláez, M; García-Gutiérrez, MD; García-Martin, A; Real-Campaña, JM; Ginés-Palomares, A; Such-Díaz, A; Vallvé-Alcon, E; Alonso-Ramos, H.

    Impact on safety and cost of pharmaceutical interventions in the emergency department (INTERPHAR): a standardized methodology for multicenter documentation

    Emergencias. 2025; 37(5): Nº de citas: 1 [doi:10.55633/s3me/082.2025]

  • Soto-Alsar, J; Revuelta-Herrero, JL; Villanueva-Bueno, C; Cobos-Lama, C; Cañete-Muñoz, MA; Muñoz-Martin, A; Garcia-Alfonso, P; Soto-Alvarez, J.

    Budget impact analysis of new drugs in oncology and haematology: Principles and practice

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2025; : Nº de citas: 1 [doi:10.1002/bcp.70303]

  • Perez-Encinas, M; Negro-Vega, E; Fernández-Llamazares, CM.

    2022 SEFH national survey on hospital pharmacy services in Spain: Human resources, infrastructure, technology, information systems, education and research

    FARMACIA HOSPITALARIA. 2025; 49(5): 312-320 [doi:10.1016/j.farma.2025.08.002]

  • Pérez-Encinas M; Negro-Vega E; Fernández-Llamazares CM.

    2022 SEFH national survey on hospital pharmacy services in Spain: Human resources, infrastructure, technology, information systems, education and research.

    FARMACIA HOSPITALARIA. 2025; 49(5): 312-320 [doi:10.1016/j.farma.2025.05.006]

  • Yuste, I; Luciano, FC; Rodríguez, C; Ramirez, BI; Rapti, C; Anaya, BJ; Lalatsa, A; Ribed-Sánchez, A; Sanz-Ruiz, P; González-Burgos, E; Serrano, DR.

    Antimicrobial 3D printed implants for periprosthetic joint infections

    Drug Delivery and Translational Research. 2025; 16: 1333-1348 Nº de citas: 2 [doi:10.1007/s13346-025-01934-5]

  • del-Barrio-Buesa, S; Narrillos-Moraza, A; García-de-Pedro, J; de-Castro-Martínez, FJ; Durán-García, ME; Escudero-Vilaplana, V; Lobato-Matilla, E; Romero-Jimenez, R; Chamorro-de-Vega, E; Ruiz-Briones, P; Garcia-Moreno, FJ; Martín-Bartolomé, M; Herranz, A; Sanjurjo, M.

    Monoclonal antibodies in severe asthma: outcomes from real-world data

    Frontiers in Medicine. 2025; 12: [doi:10.3389/fmed.2025.1635688]

  • Gomez-Llobell, M; Smith, CS; Gómez-Costas, D; Gómez-Centurión, I; Domínguez, JMG; Escudero-Vilaplana, V; Bullido, YF; Carbonell, D; Pion, M; Bailén, R; Gil-Perotin, S; Ginés, MLM; Revuelta-Herrero, JL; Fernández-Caldas, P; Fernández, VAP; Collado-Borrell, R; Bastos-Oreiro, M; Villanueva-Bueno, C; García-Sanz, R; Kwon, M.

    ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling

    BONE MARROW TRANSPLANTATION. 2025; 60: 1351-1360 Nº de citas: 12 [doi:10.1038/s41409-025-02679-y]

  • Simoes, AR; González, SC; Lopez-Doldan, MD; Duran, G; Fernández-Montes, A; Fernandez, MP; Fernandez, MS; Mata, JG; Paez, D; Riera, P; Guino, E; Lopez-Fernandez, L; de Santiago, BG; Aspiroz, EL; Rojas, A; Castells, A; Castellvi-Bel, S; Ponte, CR; Vymetalkova, V; Carracedo, A; Fernandez-Rozadilla, C.

    Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer

    BRITISH JOURNAL OF PHARMACOLOGY. 2025; 182: 5340-5354 Nº de citas: 2 [doi:10.1111/bph.70051]